Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme

por Abramov-Harpaz, Karina, Miller, Yifat
Publicado 2022

Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA(2)-Mediated Activation

por Markovic, Milica, Abramov-Harpaz, Karina, Regev, Clil, Ben-Shabat, Shimon, Aponick, Aaron, Zimmermann, Ellen M., Miller, Yifat, Dahan, Arik
Publicado 2022

PLA(2)-Triggered Activation of Cyclosporine-Phospholipid Prodrug as a Drug Targeting Approach in Inflammatory Bowel Disease Therapy

por Markovic, Milica, Ben-Shabat, Shimon, Nagendra Manda, Jagadeesh, Abramov-Harpaz, Karina, Regev, Clil, Miller, Yifat, Aponick, Aaron, Zimmermann, Ellen M., Dahan, Arik
Publicado 2022